|
Rhenium Liposome Treatment Clinical Trials
1 actively recruiting trial across 1 location
Also known as: Rhenium-186 NanoLiposome
Manhasset, New York1 trial
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
Northshore University Hospital
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.